Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sepracor has published results from its phase IIIB/IV study showing that Lunesta was effective for the treatment of insomnia in perimenopausal and menopausal women.
Subscribe to our email newsletter
Patients treated with Lunesta demonstrated statistically significant improvement in measures of onset of sleep time spent awake and total sleep time. Secondary measures of sleep quality, depth of sleep, daytime alertness, ability to function, ability to concentrate and physical well-being were also statistically significant.
Measures of other menopausal symptoms, including mood, quality of life, and impairment in daily activities were also assessed in this study. As compared with placebo, patients administered Lunesta demonstrated a greater reduction from baseline in nighttime awakenings due to hot flashes and a significant improvement in mood.
“This study of Lunesta in women experiencing perimenopausal symptoms suggests that Lunesta may provide them with relief from insomnia and therefore could lead to a significant improvement in their quality of life,” said Claudio Soares, associate professor, Department of Psychiatry and Behavioral Neurosciences, McMaster University.